Rigshospitalet is the largest hospital in Denmark and the most highly specialised hospital in the country. The hospital's main building is a 16-storey functionalist highrise, one of the tallest structures in the central parts of the city.

There are 1,118 beds in Department of Pediatrics, Rigshospitalet.

During the past decade, Department of Pediatrics, Rigshospitalet conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Department of Pediatrics, Rigshospitalet" #1 sponsor was "Rigshospitalet, Denmark" with 6 trials, followed by "Bayer" with 2 trials sponsored, "Mats Heyman" with 2 trials sponsored, "Nordic Society for Pediatric Hematology and Oncology" with 2 trials sponsored and "Aarhus University Hospital" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Pediatrics, Rigshospitalet" #1 collaborator was "Nordic Society for Pediatric Hematology and Oncology" with 4 trials as a collaborator, "Danish Cancer Society" with 2 trials as a collaborator, "Danish Child Cancer Foundation" with 2 trials as a collaborator, "NordForsk" with 2 trials as a collaborator and "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Department of Pediatrics, Rigshospitalet" are "Acute Lymphoblastic Leukemia" (5 trials), "Leukemia, Acute Lymphoblastic" (2 trials), "Viral Infection" (2 trials), "Acute Lymphoblastic Leukemia (ALL)" (1 trials) and "Bacteremia" (1 trials). Many other conditions were trialed in "Department of Pediatrics, Rigshospitalet" in a lesser frequency.

Most popular intervention types in "Department of Pediatrics, Rigshospitalet" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-mercaptopurine" (1 trials), "6-tioguanine+Standard Maintenance Therapy" (1 trials), "6MPfixed" (1 trials), "6MPindividualized" (1 trials) and "Blinatumomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Pediatrics, Rigshospitalet" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Department of Pediatrics, Rigshospitalet". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Department of Pediatrics, Rigshospitalet, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Pediatrics, Rigshospitalet, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".